CD8A and neoplasm: Hypoxia promotes CAF recruitment, connective tissue hyperplasia and activation (77), and transforming growth factor-β expression in CAFs, resulting in the exclusion of CD8+ T cells from the tumor parenchyma to hinder antitumor immunity following immunotherapy (78, 79).